Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

被引:0
|
作者
Massimo Granai
Lucia Mundo
Ayse U. Akarca
Maria Chiara Siciliano
Hasan Rizvi
Virginia Mancini
Noel Onyango
Joshua Nyagol
Nicholas Othieno Abinya
Ibrahim Maha
Sandra Margielewska
Wenbin Wei
Michele Bibas
Pier Paolo Piccaluga
Leticia Quintanilla-Martinez
Falko Fend
Stefano Lazzi
Lorenzo Leoncini
Teresa Marafioti
机构
[1] University of Siena,Department of Medical Biotechnology
[2] Institute of Pathology,University Hospital of Tübingen
[3] University College London,Department of Pathology
[4] Barts Health NHS Trust,Department of Cellular Pathology
[5] University of Nairobi,Department of Clinical Medicine and Therapeutics
[6] University of Nairobi,Department of Human Pathology
[7] Assiut University,South Egypt Cancer Institute
[8] University of Birmingham,Institute of Immunology and Immunotherapy
[9] Durham University,Department of Biosciences
[10] National Institute for Infectious Diseases “Lazzaro Spallanzani” I.R.C.C.S,Clinical Department
[11] Bologna; Euro-Mediterranean Institute of Science and Technology (IEMEST),Department of Experimental, Diagnostic, and Specialty Medicine Bologna University Medical School
[12] Department of Pathology,Department of Cellular Pathology
[13] JKUAT,undefined
[14] University College Hospital,undefined
来源
Infectious Agents and Cancer | / 15卷
关键词
Burkitt lymphoma; Tumour microenvironment; EBV; PD-L1; Immunotherapy; Immune checkpoint;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 7 条
  • [1] Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
    Granai, Massimo
    Mundo, Lucia
    Akarca, Ayse U.
    Siciliano, Maria Chiara
    Rizvi, Hasan
    Mancini, Virginia
    Onyango, Noel
    Nyagol, Joshua
    Abinya, Nicholas Othieno
    Maha, Ibrahim
    Margielewska, Sandra
    Wi, Wenbin
    Bibas, Michele
    Piccaluga, Pier Paolo
    Quintanilla-Martinez, Leticia
    Fend, Falko
    Lazzi, Stefano
    Leoncini, Lorenzo
    Marafioti, Teresa
    INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [2] Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset
    Mei Luo
    Rui Tang
    Haijun Wang
    Journal of Neuro-Oncology, 2023, 163 : 663 - 674
  • [3] Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset
    Luo, Mei
    Tang, Rui
    Wang, Haijun
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (03) : 663 - 674
  • [4] MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
    Lin, Jinti
    Xu, Ankai
    Jin, Jiakang
    Zhang, Man
    Lou, Jianan
    Qian, Chao
    Zhu, Jian
    Wang, Yitian
    Yang, Zhengming
    Li, Xiumao
    Yu, Wei
    Liu, Bing
    Tao, Huimin
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [5] A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models
    Delcanale, Pietro
    Alampi, Manuela Maria
    Mussini, Andrea
    Fumarola, Claudia
    Galetti, Maricla
    Petronini, Pier Giorgio
    Viappiani, Cristiano
    Bruno, Stefano
    Abbruzzetti, Stefania
    PHARMACEUTICS, 2023, 15 (12)
  • [6] PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer
    Sumitomo, Ryota
    Hirai, Tatsuya
    Fujita, Masaaki
    Murakami, Hiroaki
    Otake, Yosuke
    Huang, Cheng-long
    LUNG CANCER, 2019, 136 : 136 - 144
  • [7] NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer
    Yang, Yiran
    Cao, Leiqun
    Xu, Xin
    Li, Dan
    Deng, Yiran
    Li, Lan
    Zeng, Bingjie
    Jiang, Haixia
    Shan, Liang
    Huang, Yiwen
    Xu, Yunhua
    Ma, Lifang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)